Bruguiesulfurol

Details

Top
Internal ID 72b94525-601a-4111-af81-555cd2067bb0
Taxonomy Organoheterocyclic compounds > Dithiolanes > 1,2-dithiolanes
IUPAC Name (4R)-1,1-dioxodithiolan-4-ol
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C3H6O3S2/c4-3-1-7-8(5,6)2-3/h3-4H,1-2H2/t3-/m1/s1
InChI Key NGIJTYOKLKCHNE-GSVOUGTGSA-N
Popularity 4 references in papers

Physical and Chemical Properties

Top
Molecular Formula C3H6O3S2
Molecular Weight 154.21 g/mol
Exact Mass 153.97583640 g/mol
Topological Polar Surface Area (TPSA) 88.10 Ų
XlogP -0.80
Atomic LogP (AlogP) -0.58
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 0

Synonyms

Top
(4R)-1,1-dioxodithiolan-4-ol
885328-53-0
RefChem:121744
CHEMBL2419097
SCHEMBL29566665
GLXC-03825
BDBM50439605
(4R)-1,2-Dithiolan-4-ol, 1,1-dioxide

2D Structure

Top
2D Structure of Bruguiesulfurol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9455 94.55%
Caco-2 + 0.5489 54.89%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability + 0.5429 54.29%
Subcellular localzation Mitochondria 0.5950 59.50%
OATP2B1 inhibitior - 0.8608 86.08%
OATP1B1 inhibitior + 0.9756 97.56%
OATP1B3 inhibitior + 0.9422 94.22%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9554 95.54%
P-glycoprotein inhibitior - 0.9836 98.36%
P-glycoprotein substrate - 0.9797 97.97%
CYP3A4 substrate - 0.6782 67.82%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.7990 79.90%
CYP3A4 inhibition - 0.9692 96.92%
CYP2C9 inhibition - 0.7441 74.41%
CYP2C19 inhibition - 0.6527 65.27%
CYP2D6 inhibition - 0.8891 88.91%
CYP1A2 inhibition - 0.7201 72.01%
CYP2C8 inhibition - 0.9785 97.85%
CYP inhibitory promiscuity - 0.9331 93.31%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.5389 53.89%
Carcinogenicity (trinary) Non-required 0.5695 56.95%
Eye corrosion - 0.8426 84.26%
Eye irritation + 0.9494 94.94%
Skin irritation - 0.6630 66.30%
Skin corrosion - 0.8276 82.76%
Ames mutagenesis - 0.6200 62.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7270 72.70%
Micronuclear + 0.7800 78.00%
Hepatotoxicity + 0.6625 66.25%
skin sensitisation - 0.7149 71.49%
Respiratory toxicity - 0.6000 60.00%
Reproductive toxicity + 0.5111 51.11%
Mitochondrial toxicity - 0.6625 66.25%
Nephrotoxicity + 0.5505 55.05%
Acute Oral Toxicity (c) III 0.5645 56.45%
Estrogen receptor binding - 0.8638 86.38%
Androgen receptor binding - 0.7970 79.70%
Thyroid receptor binding - 0.6959 69.59%
Glucocorticoid receptor binding - 0.8447 84.47%
Aromatase binding - 0.8674 86.74%
PPAR gamma - 0.8245 82.45%
Honey bee toxicity - 0.7116 71.16%
Biodegradation - 0.5750 57.50%
Crustacea aquatic toxicity - 0.5500 55.00%
Fish aquatic toxicity - 0.4430 44.30%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 17500 nM
IC50
PMID: 23942421

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.69% 96.09%

Cross-Links

Top
PubChem 11513780
NPASS NPC202651
ChEMBL CHEMBL2419097
LOTUS LTS0127544
wikiData Q104400261